System Lupus Erythematosus
17
1
1
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 17 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (17)
Assessing the Impact of Herbal Supplement on Fatigue and Disease Activity in SLE: Results From an 8-Week Randomized Trial
Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases
The Value of Interleukin-1β and Interleukin-33 Genetic Expression in the Pathogenesis and Differentiation of Primary ITP and SLE-Related Thrombocytopenia
Vagus Nerve Stimulation for Fatigue in Systemic Lupus
Individual Patient Expanded Access IND of Autologous HB-adMSCs for the Treatment of Systemic Lupus Erythematosus (SLE)
Myofascial Techniques and Proprioceptive Neuromuscular Facilitation in Patients With Systemic Lupus Erythematosus.
A Study of SCTB35 in Patients with Systemic Lupus Erythematosus
Monitoring of Inflammatory Conditions
Systemic Lupus Erythematosus
Steroid-induced Diabetes Mellitus in Systemic Lupus Erythematosus (SLE) Patients
NCF Gene & TNFSF4 in SLE Patients
Cardiovascular Protective Role of Laser Acupuncture in Systemic Lupus
NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity
Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic
Neuromuscular Ultrasonography Utility for Detection of Peripheral Neuropathy in Systemic Lupus Erythematosus
FLARE Lupus Research Study Systemic Lupus Erythematosus
Pilot Trial of Mesenchymal Stem Cells for Systemic Lupus Erythematosus